Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan-Reference-Cited by-同舟云学术

Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan

Published:2023-03-09 Issue:2 Volume:40 Page:131-138
ISSN:2146-3123
Container-title:Balkan Medical Journal
language:
Short-container-title:Balkan Med J

Author:

Liu Hsi-Ling,Chen Yi-Hsien,Chung Chi-Hsiang,Wu Gwo-Jang,Tsao Chang-Huei,Sun Chien-An,Chien Wu-Chien,Hung Chih-Tsung

Publisher

Galenos Yayinevi

Subject

General Medicine

Reference34 articles.

1. 1. Mladosievicova B, Bernadic M. Developing strategies for long-term follow up of cancer survivors. Bratisl Lek Listy. 2002;103:390-392. [CrossRef]

2. 2. Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol. 2003;21:1352-1358. Erratum in: J Clin Oncol. 2003;21:3181. [CrossRef]

3. 3. Heydari K, Shamshirian A, Lotfi-Foroushani P, et al. The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis. Clin Transl Oncol. 2020;22:1825-1837. [CrossRef]

4. 4. Rizzo JD, Curtis RE, Socié G, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009;113:1175-1183. [CrossRef]

5. 5. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care. 2005;20:12-19. [CrossRef]

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects;TRANSPL CELL THER;2024

2. Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects;Transplantation and Cellular Therapy;2024-07